Subscriber ContentRead Preview
As big drug firms buy up smaller, speciality outfits and their most innovative products, better pipelines and sales-force efficiency will boost profits.
Popular unrest in Egypt wasn't on anyone's list of 2011 market risks. And it's not the root cause of last week's selling.
Congressional report on financial meltdown highlights divergent views of Democrats and Republicans.
Despite assurances that 2011 will be a banner year for stocks, investors are looking at earnings and quietly buying bearish puts.
Qualcomm, in the age of wireless communications, is looking like a solid investment. Also, Microsoft has plenty of factors now that could lift its shares.
Housing also crashed in Europe, Down Under. How's that U.S. institutions' fault?
In-depth, comprehensive real-time and daily market data.
Barron's comprehensive collection of weekly data.
Track the performances of stocks Barron's has written about.
Get fundamental analysis of 5,800 stocks plus in-depth reports.
More tools and data:
Subscriber Content Read Preview
A weak quarterly forecast has sent shares of the online retailing giant tumbling. We, however, think the stock is priced to buy.
This feature tracks the performance of stocks Barron's has written about during 2011 -- both favorably and critically. For stocks featured in Barron's print magazine, prices are measured from the Friday before publication date to their current price. For stocks featured on Barrons.com, prices are measured from the trading day of publication date to their current price. This list includes U.S. stocks only, including ADRs, but not foreign stocks.
Editor and President Ed Finn explains how you can use Barron's to become a better investor. Watch video